Canada could save an estimated $280 million a year in drug costs if biosimilar uptake here reached the levels seen in Norway, a speaker told attendees at a recent event in Calgary. “One problem with biosimilars is their uptake,” Andrea Staruch, a pharmacy services consultant at Green Shield Canada, said during a presentation at Benefits […]
The Ontario Human Rights Tribunal’s recent ruling that it’s unconstitutional for plan sponsors to discontinue benefits for employees after the age of 65 represents a fundamental shift for employers, according to one labour and employment lawyer. “Previously, the Human Rights Tribunal would not enforce any discrimination issues if employers were to cut off benefits at […]
Despite not yet announcing its election platform, Ontario’s Progressive Conservative Party may have the greatest potential for affecting pensions and benefits in Ontario. “The Conservatives’ broad focus on balancing the budget, which may result in their rationalizing OHIP and delisting some services, represents the real impact potential in this election,” says Anneliesje Warner, a health […]
Insurance companies expect health costs to rise by 11.8 per cent this year, according to an annual survey by Accompass Inc. The survey determines the anticipated year-over-year cost increase or decrease — or health trend factor — by asking insurers to examine their businesses and take various factors into account, including legislation, claims utilization, inflation, fee increases […]
With pharmacare, drug pricing reforms and other changes on government agendas, plan sponsors face a shifting environment for their drug plans. What should they expect? Participants at the Face to Face Drug Plan Management forum in Vancouver got a primer on some of the issues. The conference, which took place on May 1 at the […]
With governments having announced a number of changes related to pharmaceutical policy, plan sponsors are facing a shifting environment for their drug plans. “There are a lot of things happening today in the world of pharmaceuticals, drug plans, benefit plans, pricing, reimbursement and access to drugs,” said Wayne Critchley, senior associate for the health and […]
From drug pooling to medical marijuana, plan sponsors have a number of issues to keep track of when it comes to their benefits plans. At the Face to Face Drug Plan Management forum in Vancouver this month, a panel of experts tackled some of the hot topics the industry is thinking about. Pooling: One concern […]
What’s the future of health benefits in Canada? A hybrid model of core coverage and personalized benefits is a likely scenario, speakers at an event in Toronto said on Wednesday. “Our vision is really a hybrid model, where you have this traditional benefit program there to support your employee should something happen, something unpredictable that […]
It’s not often that the issues relevant to benefits plans emerge as an area of focus in the political realm. But with votes up for grabs and politicians eager to find any way to harness them, it appears issues of drugs and dental care are moving up the political agenda. In the federal arena, the […]
As the debate over pharmacare heats up, a new report released by the C.D. Howe Institute is suggesting expanded public coverage for dental services. “Many Canadians today, including most of the working poor and the retired, are covered neither by government programs nor by private insurance,” said Ake Blomqvist, an adjunct research professor at Carleton […]